NGM Bio to Participate in Upcoming Investor Conferences

Rhea-AI Summary

NGM Biopharmaceuticals, Inc. (NGM) announced CEO David J. Woodhouse, Ph.D. will present at several upcoming virtual investor conferences. The Stifel 2021 Virtual Healthcare Conference will take place on November 15, 2021, at 2:40 p.m. ET. The Jefferies London Healthcare Conference is scheduled for November 18-19, with an on-demand presentation starting November 18 at 3:00 a.m. ET. The Piper Sandler Healthcare Conference occurs from November 30 to December 2, 2021, with an on-demand presentation available November 22, and the Evercore ISI Healthcare Conference on December 1 at 1:25 p.m. ET.

SOUTH SAN FRANCISCO, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced that David J. Woodhouse, Ph.D., Chief Executive Officer, will present an overview of the company and provide a business update at the following upcoming 2021 virtual investor conferences:

Stifel 2021 Virtual Healthcare Conference
Monday, November 15, 2021, 2:40pm ET

Jefferies London Healthcare Conference
Thursday-Friday, November 18-19, 2021; presentation available on-demand beginning November 18, 2021, 3:00am ET

33rd Annual Piper Sandler Healthcare Conference
Tuesday-Thursday, November 30-December 2, 2021; presentation available on-demand beginning November 22, 2021, 10:00am ET

Evercore ISI Healthcare Conference
Wednesday, December 1, 2021, 1:25pm ET

Live webcasts of presentations will be available under the Investors and Media section of NGM’s website at https://ir.ngmbio.com/events-presentations. A replay of each presentation will be archived on NGM’s site for at least 30 days following the event.

About NGM Biopharmaceuticals, Inc.

NGM is a biopharmaceutical company focused on discovering and developing novel therapeutics based on scientific understanding of key biological pathways underlying retinal diseases, cancer and liver and metabolic diseases. We leverage our biology-centric drug discovery approach to uncover novel mechanisms of action and generate proprietary insights that enable us to move rapidly into proof-of-concept studies and deliver potential first-in-class medicines to patients. At NGM, we aspire to operate one of the most productive research and development engines in the biopharmaceutical industry. All of our therapeutics have been generated by our in-house discovery engine; today, we have seven disclosed programs, including four in Phase 2 or 2b studies, across three therapeutics areas. Visit us at www.ngmbio.com for more information.

Investor Contact: Brian Schoelkopf ir@ngmbio.com

Media Contact: Liz Melone media@ngmbio.com

FAQ

When will NGM Biopharmaceuticals present at the Stifel Healthcare Conference?

NGM Biopharmaceuticals will present at the Stifel 2021 Virtual Healthcare Conference on November 15, 2021, at 2:40 p.m. ET.

What is the schedule for NGM Biopharmaceuticals at the Jefferies London Healthcare Conference?

NGM will have an on-demand presentation available starting November 18, 2021, at 3:00 a.m. ET during the Jefferies London Healthcare Conference, taking place from November 18-19.

When is the Piper Sandler Healthcare Conference where NGM will present?

The Piper Sandler Healthcare Conference is scheduled for November 30 to December 2, 2021, with an on-demand presentation available starting November 22, 2021, at 10:00 a.m. ET.

What date and time will NGM Biopharmaceuticals present at the Evercore ISI Healthcare Conference?

NGM Biopharmaceuticals will present at the Evercore ISI Healthcare Conference on December 1, 2021, at 1:25 p.m. ET.

Where can I watch NGM Biopharmaceuticals' conference presentations?

Live webcasts of NGM's presentations will be available on their website under the Investors and Media section, and replays will be archived for at least 30 days following each event.